Abstract Details

Title A Descriptive Analysis of Prognostic Indicators in Patients with Non-Convulsive Status Epilepticus in a Tertiary Hospital Population

Topic Epilepsy

Presentation(s) (-)

Poster/Presentation
Number 213

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Chantelle T. Hrazdil, MD (Vancouver Coastal Health)	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
	No disclosure on file
Manouchehr Javidan, MD	No disclosure on file

��ɫ��